Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic

Paul Z Chen¹, Marion Koopmans², David N Fisman³, Frank X Gu⁴

Affiliations

¹ Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada.
² Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands.
³ Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
⁴ Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada. Electronic address: f.gu@utoronto.ca.

PMID: 34352224
PMCID: PMC8328407
DOI: 10.1016/S1473-3099(21)00406-0

Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic

Paul Z Chen et al. Lancet Infect Dis. 2021 Sep.

. 2021 Sep;21(9):1203-1204.

doi: 10.1016/S1473-3099(21)00406-0. Epub 2021 Aug 2.

Authors

Paul Z Chen¹, Marion Koopmans², David N Fisman³, Frank X Gu⁴

Affiliations

¹ Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada.
² Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands.
³ Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
⁴ Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada. Electronic address: f.gu@utoronto.ca.

PMID: 34352224
PMCID: PMC8328407
DOI: 10.1016/S1473-3099(21)00406-0

No abstract available

PubMed Disclaimer

Conflict of interest statement

DNF reports serving on advisory boards of Seqirus, Sanofi Pasteur, Pfizer, and AstraZeneca, and consulting for the Ontario Nurses Association, Elementary Teachers' Federation of Ontario, JP Morgan-Chase, WE Foundation, and Farallon Capital, outside the submitted work. FXG is supported by the Natural Sciences and Engineering Research Council of Canada and Toronto COVID-19 Action Fund. All other authors declare no competing interests.

References

1. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438:355–359. - PMC - PubMed
1. Sun K, Wang W, Gao L, et al. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 2021;371(6526) - PMC - PubMed
1. Lau MSY, Grenfell B, Thomas M, Bryan M, Nelson K, Lopman B. Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA. Proc Natl Acad Sci USA. 2020;117:22430–22435. - PMC - PubMed
1. Hasan A, Susanto H, Kasim MF, et al. Superspreading in early transmissions of COVID-19 in Indonesia. Sci Rep. 2020;10 - PMC - PubMed
1. Brugger J, Althaus CL. Transmission of and susceptibility to seasonal influenza in Switzerland from 2003 to 2015. Epidemics. 2020;30 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic

Affiliations

Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic

Authors

Affiliations

Conflict of interest statement

References

MeSH terms

LinkOut - more resources

Full Text Sources

Medical